Ryzodeg 70/30
Drug
Novo Nordisk AS
Total Payments
$3.6M
Transactions
987
Doctors
28
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $95.00 | 5 | 5 |
| 2021 | $224.28 | 3 | 3 |
| 2020 | $6,812 | 10 | 4 |
| 2019 | $44,787 | 29 | 3 |
| 2018 | $738,342 | 107 | 4 |
| 2017 | $2.9M | 833 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.5M | 891 | 96.5% |
| Travel and Lodging | $88,876 | 41 | 2.4% |
| Consulting Fee | $37,320 | 29 | 1.0% |
| Food and Beverage | $1,311 | 24 | 0.0% |
| Education | $674.75 | 1 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $186.50 | 1 | 0.0% |
Payments by Type
Research
$3.5M
891 transactions
General
$128,368
96 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NN5401-4266 | Novo Nordisk AS | $3.5M | 0 |
| EX1250-4080 | Novo Nordisk AS | $6,715 | 0 |
Top Doctors Receiving Payments for Ryzodeg 70/30
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Roswell, GA | $3.5M | 891 |
| , M.D | Endocrinology, Diabetes & Metabolism | La Jolla, CA | $41,009 | 25 |
| , M.D.,F.A.C.P | Endocrinology, Diabetes & Metabolism | Fresh Meadows, NY | $16,996 | 4 |
| , M.D | Endocrinology, Diabetes & Metabolism | Nashua, NH | $13,324 | 9 |
| , M.D | Endocrinology, Diabetes & Metabolism | Boston, MA | $13,183 | 6 |
| , M.D | Family Medicine | Kingsport, TN | $13,081 | 4 |
| , MD | Emergency Medicine | Midlothian, VA | $11,117 | 4 |
| Gary Bedel | — | Franklin, OH | $9,670 | 4 |
| , MD PHD | Internal Medicine | Boston, MA | $6,770 | 6 |
| , M.D | Neurology | Brighton, MA | $825.00 | 4 |
| , M.D | Cardiovascular Disease | Lawrenceville, GA | $570.00 | 4 |
| , MD | Neurology | Brighton, MA | $550.00 | 2 |
| , M.D | Internal Medicine | Boston, MA | $405.00 | 3 |
| , M.D | Neurology | Boston, MA | $385.00 | 4 |
| Anjan Chakrabarti | Internal Medicine | Chesapeake, VA | $165.00 | 1 |
| , M.D | Interventional Cardiology | Boston, MA | $110.00 | 2 |
| , P.A | Physician Assistant | Lebanon, TN | $19.00 | 1 |
| , PA | Physician Assistant | Chattanooga, TN | $19.00 | 1 |
| , MD | Pediatrics | Lebanon, TN | $19.00 | 1 |
| , MD | Pediatrics | Lebanon, TN | $19.00 | 1 |
| , M.D | Family Medicine | Lebanon, TN | $19.00 | 1 |
| , D.O | Family Medicine | Dayton, OH | $18.89 | 1 |
| , FNP | Family | Dayton, OH | $18.89 | 1 |
| , D.O | Family Medicine | Crossville, TN | $18.09 | 2 |
| , M.D | Family Medicine | Marlette, MI | $14.84 | 1 |
Ad
Manufacturing Companies
- Novo Nordisk AS $3.6M
- Novo Nordisk Inc $44,994
Product Information
- Type Drug
- Total Payments $3.6M
- Total Doctors 28
- Transactions 987
About Ryzodeg 70/30
Ryzodeg 70/30 is a drug associated with $3.6M in payments to 28 healthcare providers, recorded across 987 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk AS.
Payment data is available from 2017 to 2022. In 2022, $95.00 was paid across 5 transactions to 5 doctors.
The most common payment nature for Ryzodeg 70/30 is "Unspecified" ($3.5M, 96.5% of total).
Ryzodeg 70/30 is associated with 2 research studies, including "NN5401-4266" ($3.5M).